**
A groundbreaking maternal vaccine is proving to be a game-changer in the fight against respiratory syncytial virus (RSV), significantly reducing hospital admissions for newborns by over 80%, according to UK health officials. The vaccine, administered during pregnancy, offers vital protection against severe chest infections, which affect thousands of infants each year, highlighting the importance of maternal health interventions.
The Threat of RSV
RSV poses a serious risk to infants, particularly in their first few months of life. Each year, more than 20,000 babies in the UK are admitted to hospital due to severe infections caused by this virus. Symptoms can range from mild respiratory issues to life-threatening conditions that leave infants struggling to breathe and feed. Dr Conall Watson, the national programme lead for RSV at the UK Health Security Agency (UKHSA), notes the alarming nature of these infections. “In babies with severe infections, you can see their chest and lungs struggling, as they try to pull enough oxygen in,” he explained. “This is very frightening for parents, and rightly so.”
A Promising Solution
In 2024, the UK introduced a vaccine aimed at protecting newborns from RSV. Offered to pregnant women from 28 weeks, the vaccine has been shown to enhance a mother’s immune response, allowing her to pass on protective antibodies to her baby through the placenta. Recent studies indicate that when administered at least four weeks prior to delivery, the vaccine can provide nearly 85% protection against RSV. Even if given within two weeks of birth, some level of immunity can still be conferred.
Dr Watson emphasises the importance of timely vaccination: “If you have a longer interval between when the vaccine is given and when the baby is born, then you achieve even better protection. It’s essential to get vaccinated on time, but if that’s not possible, receiving the vaccine during the third trimester is still beneficial.”
Real-World Impact of the Vaccine
A comprehensive study encompassing nearly 300,000 births in England between September 2024 and March 2025 revealed that over 4,500 babies were admitted to hospital due to RSV, with the vast majority being infants whose mothers had not received the vaccine.
The experience of Laine Lewis, whose son Malachi suffered severe complications from RSV, underscores the urgency of this vaccination programme. Although Malachi was not vaccinated in time and was hospitalised with RSV after developing a cold, Laine stresses that her son’s case is rare. “I’d encourage people to take the vaccine for RSV because it will help their child,” she said, advocating for increased awareness around the vaccine’s benefits.
Current Vaccination Rates and Recommendations
While the latest data indicates that approximately 64% of pregnant women in England are receiving the RSV vaccine, this figure drops to 53% in London. Alongside the RSV vaccine, pregnant individuals are also advised to get vaccinated against flu and whooping cough to further safeguard both their health and that of their newborns. Additionally, the vaccine is available to older adults, particularly those aged 75 and over or residing in care homes.
Dr Watson encourages expectant mothers to engage with their midwives and healthcare professionals about the vaccine. “I would strongly encourage any pregnant woman to discuss it with their midwife, other health professionals, and be ready to have the vaccine at their week 28 appointment, or to arrange another appointment soon after.”
Why it Matters
The introduction of the RSV vaccine for pregnant women represents a significant advancement in paediatric health, potentially saving thousands of infants from severe illness and hospitalisation. By enhancing maternal immunity and transferring protection to newborns, this vaccine not only alleviates the burden on healthcare systems but also provides peace of mind for parents during a vulnerable time. As awareness and vaccination rates increase, we may see a substantial decline in RSV-related hospital admissions, ultimately safeguarding the health of future generations.
